- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Flt3
Total 157 results
-
Ayman H QasrawiAstellas Pharma IncWithdrawn
-
AmgenWithdrawnRelapsed/Refractory Acute Myeloid LeukemiaUnited States
-
Versailles HospitalActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia With FLT3/ITD MutationUnited States
-
Nanfang Hospital of Southern Medical UniversityEnrolling by invitationAcute Myeloid Leukemia | FLT3-ITD Mutation | Brutons Tyrosine KinaseChina
-
National Cancer Institute (NCI)CompletedTherapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | FLT3 Gene Mutation | Acute Promyelocytic Leukemia With PML-RARA | Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1United States
-
Novartis PharmaceuticalsNo longer availableFLT3-mutated Acute Myeloid LeukemiaCanada
-
Arog Pharmaceuticals, Inc.CompletedPhase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsRelapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States
-
Arog Pharmaceuticals, Inc.CompletedNewly Diagnosed AML With FLT3 Activating MutationsUnited States
-
Nanfang Hospital of Southern Medical UniversityXiangya Hospital of Central South University; Peking University People's Hospital and other collaboratorsCompletedAcute Myeloid Leukemia | Hematopoietic Stem Cell Transplantation | Acute Myeloid Leukemia With FLT3/ITD MutationChina
-
University of UlmTerminated
-
Shijiazhuang Yiling Pharmaceutical Co. LtdNot yet recruitingAcute Myeloid Leukemia With FLT3/ITD Mutation
-
Arog Pharmaceuticals, Inc.WithdrawnRelapsed/Refractory FLT3-mutated AML
-
Nanfang Hospital of Southern Medical UniversityRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Acute Myeloid Leukemia With FLT3/ITD MutationChina
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Nanfang Hospital of Southern Medical UniversityXiangya Hospital of Central South University; Peking University People's Hospital and other collaboratorsCompletedAcute Myeloid Leukemia | Hematopoietic Stem Cell TransplantationChina
-
Sunshine Lake Pharma Co., Ltd.Recruiting
-
Guenther KoehneJazz PharmaceuticalsRecruitingAcute Myeloid LeukemiaUnited States
-
Arog Pharmaceuticals, Inc.RecruitingRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States, Germany, Spain, Italy, France, Canada
-
Nanfang Hospital of Southern Medical UniversityXiangya Hospital of Central South University; Peking University People's Hospital and other collaboratorsRecruitingAcute Leukemia | Hematopoietic Stem Cell Transplantation | RelapseChina
-
Nanfang Hospital of Southern Medical UniversityRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Acute Myeloid Leukemia With FLT3/ITD MutationChina
-
University of Southern CaliforniaRecruitingSoft Tissue Sarcoma | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Merkel Cell Carcinoma | Unresectable Melanoma | Unresectable Breast Carcinoma | Bone Sarcoma | Sarcoma,Soft Tissue | Metastatic Breast Carcinoma | Cutaneous Squamous Cell Carcinoma and other conditionsUnited States
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Triple Negative Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)United States, Spain, Belgium, Germany, Japan, Taiwan, Turkey, Italy, Australia, Austria, Switzerland, Israel, Bulgaria, France, Norway, Brazil, Poland, Portugal, Czechia, Argentina
-
Novartis PharmaceuticalsRecruitingFLT3-mutated Acute Myeloid LeukemiaKorea, Republic of, Germany, Italy, Turkey, Czechia, Jordan, Slovenia, Austria, Poland, Japan, Russian Federation, United States, Greece
-
University Hospital MuensterCelgene Corporation; AmgenCompleted
-
Astellas Pharma Korea, Inc.RecruitingAcute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Acute Myeloid Leukemia With FLT3/ITD Mutation | Refractory Acute LeukemiaUnited States
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid LeukemiaUnited States, Spain, Netherlands, Canada, France, Germany, United Kingdom, Italy, Poland
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia | FLT3-mutated Acute Myeloid LeukemiaJapan, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia With FLT3/ITD MutationUnited States
-
Daiichi Sankyo, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Assiut UniversityNot yet recruitingAcute Myeloid Leukemia
-
Uma BorateSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics IncCompletedAcute Myeloid Leukemia | LeukemiaUnited States
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States, France, Italy, United Kingdom
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) MutationTaiwan, Poland, Serbia, United States, Brazil, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Romania, Spain, Sweden, United Kingdom
-
Astellas Pharma IncActive, not recruitingAcute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationChina, Malaysia, Russian Federation, Singapore, Thailand
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
Erasca, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaUnited States, Japan, Korea, Republic of, Taiwan, Spain, Italy, United Kingdom, Australia, Belgium, Canada, Denmark, France, Germany, Greece, New Zealand, Poland
-
Nanfang Hospital of Southern Medical UniversityRecruitingAcute Leukemia | Allogeneic Hematopoietic Stem Cell TransplantationChina
-
Novartis PharmaceuticalsNo longer availableAcute Myeloid Leukemia (AML) With | FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFLT3 Gene Mutation Negative | FLT3 Internal Tandem Duplication Positive | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic...United States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom